Published April 5, 2011
| Version v1
Patent
Open
Constitutive gene expression in conjunction with ionizing radiation
Creators
- 1. University of Chicago
- 2. Dana-Farber Cancer Institute
Contributors
Patent applicants:
Description
The present disclosure demonstrates the successful use of constitutive promoters operatively linked to genes encoding radiosensitizing or radioprotecting factors, administered to cells, tissues, or patients in conjunction with radiation exposure. Also disclosed are pharmacological preparations to be used to increase the levels of radiosensitizing compounds such as TNF-α, or radioprotective compounds such as MnSOD, in specified tissues or tumors of a subject.
Files
US7919310.pdf
Files
(1.2 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:dd7d7295fcdbd0e4d4dede79b99f11e3
|
1.2 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 1942808 A
- Patent application number
- US 7919310 B2
- Other
- oai:uchicago.tind.io:9538
Dates
- Patent filed
-
2008-01-24